Explore WARF Inventions and Patents
WARF’s portfolio of more than 1,600 patented technologies covers a wide range of categories, including analytical instrumentation, pharmaceuticals, food products, agriculture, research tools, medical devices, pluripotent stem cells, clean technology, information technology and semiconductors.
Information summaries, which describe each technology and its applications, benefits, inventors and patent status, can be downloaded, printed and shared by clicking on the technology category links to the left on this page.
Visit our subscription center to sign up for our monthly email updates and learn when new WARF technologies become available for licensing.
The system includes units for electro-oxidation, electro-deposition and electro-adsorption. These units work sequentially to (1) break the strong chemical bonds in the waste stream, (2) recover the heavy metal ions and (3) remediate the organic/inorganic material.
A primary advantage of the new system is the redesigned electro-deposition unit, which houses a concentrating cathode and helps in the recovery of metals present even in very low concentrations in a reusable form.
Some of the compounds have been tested in vitro for their ability to increase the secretion of a potent blood sugar hormone in the body called glucagon-like peptide 1 (GLP-1). Others have the ability to selectively inhibit the secretion of interleukin-17 (IL-17), which is essential in many autoimmune diseases including arthritis, multiple sclerosis, psoriasis and inflammatory bowel disease.
The synthesis process involves a cascade reaction with transition metal catalysts. The resulting compounds can be further functionalized to yield more substituted indoles.
The compound has been reported as an anticancer drug but was not previously shown to have antimicrobial properties. It was identified by searching for compounds that cause E. coli bacteria to lack a copy of the chromosome following cell division.
The researchers found that a class of compounds called acid sphingomyelinase inhibitors can be used to fight retinal disorders associated with abnormal accumulations of lipofuscin (a cellular waste product), cholesterol or increased inflammation. One such inhibitor, generic name desipramine, is currently sold on the market as an antidepressant. Other acid sphingomyelinase inhibitors also may be suitable.
The molecules inhibit the growth of microorganisms that depend on UGM to incorporate Galf residues. They also diminish the virulence of pathogenic microorganisms, such as M. tuberculosis, M. smegmatis and Klebsiella pneumonia, that rely on UGM.
The device comprises a cavity for receiving the fluid, an auger connected with an axial shaft, and a load cell sensor connected to the auger. The sensor measures the force on the auger from the fluid as the auger moves up and down. A linkage interconnected to the sensor translates motion to the auger.
Semiconductor Interconnect Design for Small, Inexpensive, Integrated Current Sensing with Improved Reliability
Various styrene-containing BCPs can be deposited on top of the film and then subjected to conditions that cause them to self-assemble into vertically oriented domains.